All of Us California Precision Medicine Consortium (CaPMC)

 

PI:Lucila Ohno-Machado
Co-PIs:Hoda Anton-Culver (UCI), Atul Butte (UCSF)
Staff:Andrea LaCroix, Cinnamon Bloss, Rita Kurtz, Michele Day
Grant:NIH: OT2OD024611
Start date of Project:9/17/2016
Expected duration of Project:8/31/2017
Description of Project:The objective of this initiative is to "engage a million or more Americans to volunteer to contribute their health data to improve health outcomes, fuel the development of new treatments, and catalyze a new era of data-based and more precise medical treatment." Subsequently, the NIH announced the PMI Cohort Program to create a national research cohort (named "All of Us") of one million or more U.S. participants. The California Precision Medicine Consortium (CAPMC) – a partnership among UC Irvine, UC San Diego, UC Davis, UC San Francisco and UC Health, along with Cedars-Sinai Medical Center, the San Diego Blood Bank and the University of Southern California – is one of four regional groups chosen by the National Institutes of Health to take part in a national network of healthcare provider organizations building the Precision Medicine Initiative's research participant group, or cohort. The Precision Medicine Initiative's objective is to create a framework by which medical treatment and prevention can be tailored to each individual. Precision medicine is a groundbreaking health care approach for disease treatment and prevention that takes into account individual differences in lifestyle, environment, and genes to better understand how we can improve and maintain a person's health.